• Mashup Score: 3

    Press releases may be edited for formatting or style | November 21, 2022 MRI Rad Oncology DETROIT (Nov. 21, 2022) – Findings from a recent prospective study show promising safety and patient outcomes data for locally advanced and borderline resectable pancreatic cancer treatment using ablative Stereotactic MRI-Guided On-table Adaptive Radiation Therapy, also known as SMART. Approximately…

    Tweet Tweets with this article
    • We recently led the largest international study for #PancreaticCancer ablative radiation treatment using stereotactic MRI-guided on-table adaptive radiation therapy (SMART). Read more from our director of GI radiation oncology, Dr. Parag Parikh: https://t.co/6VnqKC5MLv https://t.co/2R4jMbYQ0Z

  • Mashup Score: 0

    Insights from Kees Wesdorp, chief business leader of precision diagnosis at Philips

    Tweet Tweets with this article
    • “Cancer doesn’t stop, and any delay in the diagnosis and treatment in oncology care can pose a high risk to patients. The rapid adoption of digital pathology services has been critical in ensuring the continuation of clinical services during the pandemic” https://t.co/vKPNYLUgbK